Synthesis of α-glucan in mycobacteria involves a hetero-octameric complex of trehalose synthase TreS and Maltokinase Pep2 by Roy, Rana et al.
Synthesis of α‑Glucan in Mycobacteria Involves a Hetero-octameric
Complex of Trehalose Synthase TreS and Maltokinase Pep2
Rana Roy,† Veeraraghavan Usha,† Ali Kermani,† David J. Scott,‡,§ Eva I. Hyde,† Gurdyal S. Besra,*,†
Luke J. Alderwick,*,† and Klaus Fütterer*,†
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ABSTRACT: Recent evidence established that the cell envelope of
Mycobacterium tuberculosis, the bacillus causing tuberculosis (TB), is coated
by an α-glucan-containing capsule that has been implicated in persistence in a
mouse infection model. As one of three known metabolic routes to α-glucan
in mycobacteria, the cytoplasmic GlgE-pathway converts trehalose to α(1 →
4),α(1 → 6)-linked glucan in 4 steps. Whether individual reaction steps,
catalyzed by trehalose synthase TreS, maltokinase Pep2, and glycosyl-
transferases GlgE and GlgB, occur independently or in a coordinated fashion
is not known. Here, we report the crystal structure of M. tuberculosis TreS,
and show by small-angle X-ray scattering and analytical ultracentrifugation
that TreS forms tetramers in solution. Together with Pep2, TreS forms a hetero-octameric complex, and we demonstrate that
complex formation markedly accelerates maltokinase activity of Pep2. Thus, complex formation may act as part of a regulatory
mechanism of the GlgE pathway, which overall must avoid accumulation of toxic pathway intermediates, such as maltose-1-
phosphate, and optimize the use of scarce nutrients.
■ INTRODUCTION
The cell envelope of Mycobacterium tuberculosis, the organism
causing tuberculosis (TB), remains a central focus of TB
research. It contributes critically to virulence and survival in the
host, yet our understanding of how its complex architecture is
assembled is fragmentary. Pathways of cell wall synthesis
continue to be scrutinized for potential novel therapeutic
targets, which are urgently needed to help ease the burden of
the global TB epidemic and the threat posed by rising antibiotic
resistance.1−3
Evidence from cryo-electron microscopy has recently
conﬁrmed that mycobacteria are coated by a capsular layer.4
The capsular layer is composed of α-glucan (80−90%),
arabinomannan (10−20%), and proteins of the ESX-1 secretion
system,4 and could oﬀer novel serological biomarkers for TB
infection.5 The dominant component of the capsular layer, α-
glucan, is a polymer composed of α(1 → 4)-linked glucose
units with α(1 → 6)-branching. To date, three metabolic
pathways in mycobacteria are known to synthesize α-glucan (at
least as an intermediate) including the classical GlgC−GlgA
pathway, the Rv3032 pathway, and the GlgE pathway. These
pathways share common nodes or are linked by synthetic lethal
interactions.6,7 Although the α-glucan capsule is shed readily in
detergent-containing liquid cultures, a knockout of GlgA
compromised persistence of tubercle bacilli in a mouse
infection model, suggesting that persistence requires an intact
capsule.8 However, the extent to which the three pathways
contribute to the synthesis of capsular α-glucan remains to be
established. In the recently discovered 4-step GlgE pathway7,9
(Figure 1), the starting material is trehalose (α,α-1,1-diglucose),
which is isomerized to maltose (α,α-1,4-diglucose), in a step
catalyzed by M. tuberculosis trehalose synthase, TreS, followed
by phosphorylation of maltose to maltose-1-phosphate,
catalyzed by maltokinase Pep2. The phospho-activated
disaccharide is then incorporated into the growing α-(1 →
4)-glucan chain by glycosyltransferase GlgE, while glycosyl-
transferase GlgB mediates α(1→ 6)-branching of the chain.7,10
Mycobacteria can generate trehalose, a carbohydrate store and
stress protectant, from cytosolic glycogen by the TreX−TreY−
TreZ pathway or from glucose-1-phosphate via GalU and
OtsA−OtsB.6 In addition, trehalose can be recycled between
the cell wall and the cytoplasm by an ABC transporter system
that is essential for virulence.11 Such metabolic networks ensure
that M. tuberculosis makes optimal use of scarce carbohydrates, a
major limitation of its ecological niche.
Classical and reverse genetics have shown that both glgE and
glgB are essential genes, while simultaneous inactivation of the
treS gene recovered viability. In contrast, the ΔtreS deletion on
its own had no eﬀect on growth.7 This phenotypic pattern was
interpreted as the consequence of self-poisoning by the toxic
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pathway intermediate maltose-1-phosphate, as the latter is
produced (by TreS and Pep2), but not processed further.
Limitations of nutrient supply and synthesis of toxic pathway
intermediates suggest that α-glucan synthesis is subject to
regulatory control. To date we do not know what mechanisms
regulate α-glucan synthesis nor whether enzymes of the GlgE
pathway work independently or in a coordinated fashion.
Here, we report structural, biophysical, and biochemical
evidence demonstrating that formation of a large multicatalytic
complex of TreS and Pep2 aﬀects enzymatic activity of the
latter, suggesting that complex formation may be part of a
regulatory mechanism of the GlgE pathway.
■ RESULTS AND DISCUSSION
X-ray Crystal Structure of TreS. The structure of M.
tuberculosis TreS was solved by molecular replacement to a
resolution of 2.6 Å (Figure 2A,B). The asymmetric unit of the
crystal lattice contains two copies of TreS (chains A and B),
which were reﬁned using noncrystallographic symmetry
restraints. As a result, the two copies of TreS superimpose
closely with a root-mean-square deviation (rmsd) of 0.6 Å for
537 paired carbon-α (Cα) positions. The electron density
covers residues 12 to 586 (of 601 amino acids total), whereby
the uncleaved N-terminal aﬃnity-tag, as well as residues 1−11
and residues 587−601 are disordered. In addition, density is
poor or absent for residues 426−429 in chain A and residues
353−381 in chain B.
By sequence similarity, TreS belongs to family GH13 of
glycoside hydrolases (www.cazy.org).12 The prototypic struc-
tures of this large enzyme family comprise two conserved
domains: a catalytic domain with a (β/α)8 barrel-like fold
(known as the triosephosphate isomerase or TIM barrel fold),
and a C-terminal β-sandwich domain (Figures 2A,B and S1A,
Supporting Information). The closest structural neighbor
according to distance matrix alignment (DALI13) is Neisseria
polysaccharea amylosucrase (PDB entry 1ZS2,14 27% sequence
identity), aligning with an rmsd of 2.7 Å over 492 aligned Cα
positions (Figure 3A). The core TIM barrel is decorated with
extended loops, for some of which speciﬁc functional roles are
discernible (Figure S1A, Supporting Information). For instance,
the β3-β4 loop contains a calcium binding site, close to the
active site but of unknown mechanistic signiﬁcance (Figures
2A,B and S1B, Supporting Information). The β7−β8 loop folds
over the central β-barrel in chain A but is disordered in chain B
for residues 353−381, while the β6−β7 loop includes a helix-
turn-helix motif that replaces the canonical helix α6 of the TIM-
barrel fold.
The Ca2+ ion is octahedrally coordinated by Oδ1 of Asp208
and the carbonyl oxygen of Leu243 at the apexes and Asp140
and Glu245, a water molecule and the carbonyl oxygen of
Tyr242 in the central plane of the octahedron (Figure S1B,
Supporting Information). The identity of this site as calcium is
supported by strong anomalous density (7.4σ above back-
ground, calculated with diﬀraction data recorded at 1.77 Å;
Figure S1B, Supporting Information) and the overlap with a
corresponding Ca2+ site in a structural neighbor (α-amylase
SusG of Bacteroides thetaiotaomicrometer, 3K8K).15
Analysis of packing interfaces (PISA,16 www.ebi.ac.uk/msd-
srv/prot_int/pistart.html) suggested that TreS may form
tetramers in solution (2TreSA + 2TreSB, Figure 2C), with an
extensive buried solvent-accessible surface of ∼11 000 Å2.
When testing self-assembly by analytical ultracentrifugation, a
tetrameric species was found (see below). Intersubunit contacts
Figure 1. Diagram of the GlgE-pathway of mycobacterial α-glucan
synthesis. Conversion of trehalose to maltose-1-phosphate proceeds
through isomerization (TreS) and phosphorylation (Pep2) of the
disaccharide (generated with ChemBioDraw Ultra).
Figure 2. Overall fold of M. tuberculosis trehalose synthase TreS and its
tetrameric assembly in the crystal. (A) Top view of the structure, with
a (β/α)8-barrel fold (blue helices, magenta strands) as the conserved
core and an antiparallel β-sandwich domain at the C-terminus (dark
red). Selected loops connecting successive β-strands in the (β/α)8-fold
are highlighted. (B) Orthogonal view of panel A. (C) Quaternary
structure of TreS, containing 2 copies of each of chain A and B. Primes
denote copies linked by crystallographic symmetry.
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are primarily mediated by the C-terminal β-sandwich domain,
the Ca2+-binding β3−β4 loop, and at the center of the tetramer,
by the β8−α8 loop (Figure 2C).
Diﬀerential Ordering of β7−β8 Loop in the Active
Site. A recent mechanistic study has identiﬁed the catalytic
residues of TreS in the closely related (83% identity) M.
smegmatis species,17 which correspond to Asp238 (nucleo-
phile), Glu280 (general acid), and Asp350 (unknown function)
in M. tuberculosis. These residues are situated at the top (C-
terminal) rim of the β-barrel (Figure 3A). By soaking and
cocrystallization, we sought unsuccessfully to generate sub-
strate/product-bound complexes of TreS. The structure
contains several bound sulfate ions, including one in each of
the active site of chains A and B (Figure S1C, Supporting
Information). High sulfate concentrations were critical to grow
crystals of TreS and to maintain crystal stability during soaking,
promoting sulfate binding in the active site (Figure S1C,
Supporting Information), which may interfere with substrate
binding.
Superimposing chain A of TreS with sucrose-bound
structures of amylosucrase (PDB entry 1ZS214) or trehalulose
synthase (2PWE18) shows that the β7−β8 loop, containing the
catalytic Asp350, overlaps with the position of the substrate
(Figure 3B). Indeed, in sucrose-bound amylosucrase, the
β7−β8 loop is in a markedly diﬀerent conformation, with the
aspartic acid corresponding to Asp350 (Asp393) shifted away
by 3.8 Å from the substrate-binding site and forming H-bonds
with the glucosyl moiety of the sugar. In chain B of TreS,
density for the β7−β8 loop (at a 1σ contour level) is invisible
for residues 353−381, despite the bound active site sulfate,
suggesting inherent ﬂexibility of this loop.
The crystal tetramer of TreS possesses two 2-fold rotational
symmetry axes, mapping subunit A onto subunit A′ and B onto
B′ (by crystallographic symmetry), and chain A onto chain B
(A′ onto B′, by the noncrystallographic 2-fold rotation)
(Figures 2C and 3C). The active sites of each noncrystallo-
graphic pair of subunits (A−B and A′−B′) are connected by an
internal cavity or tunnel, and the substrate binding sites are
separated by about 35 Å. In a state where the β7−β8-loop is
disordered (as is the case for chain B), the active site is wide
open to solvent (Figure 3D). Yet even when this loop ordered
the active site remains solvent-accessible.
TreS-catalyzed isomerization of trehalose to maltose
proceeds through a double displacement mechanism, which
involves a covalently bound glucosyl-enzyme intermediate.17
Such mechanism raises the question whether, between
glycosylation and deglycosylation of TreS, the leaving group
(the noncovalently bound glucose molecule) diﬀuses out of the
active sit or is retained, reorients, and reattacks the covalently
bound half of the disaccharide. Recent evidence using 13C-
labeled glucose in addition to unlabeled disaccharide indicated
that no labeled glucose was incorporated into the product,
strongly suggesting that isomerization occurs without release of
the leaving glucose molecule to solvent.17 Hydrolysis of
trehalose (and maltose) to glucose occurs as a side reaction
(see below), suggesting that retention of the leaving glucose
molecule is imperfect. Nonetheless, the ordered vs disordered
state of the β7−β8 loop in chains A and B, respectively, may be
linked to enabling retention of the hydrolyzed substrate in the
active site.
In the conformation of chain A, the β7−β8 loop overlaps
with the substrate binding site (Figure 3B), but relatively minor
structural adjustments of this loop suﬃce to make space for a
disaccharide. It is conceivable that the loop acts as a clamp,
helping to hinder diﬀusion of the leaving glucose out of the
active site. Of the three catalytic carboxylic acids (Asp238,
Glu280, and Asp350),17 Asp350 is located in the β7−β8 loop.
Furthermore, in this loop, residues 350 to 366 are strictly
conserved in mycobacteria, and only two conservative
substitutions (Ser to Thr and Asp to Ser) occur in TreS of
Corynebacterium glutamicum, a nonpathogenic surrogate organ-
ism. Sequence conservation could provide conserved, speciﬁc-
ity-determining contacts with the noncovalently bound glucose.
At the same time, conformational ﬂexibility could provide
plasticity required to facilitate the reorientation of the cleaved
glucose moiety, together favoring reorientation of the leaving
glucose over release from the active site. Very recently a crystal
structure M. smegmatis TreS was determined, with structural
features consistent to our ﬁndings.19
Solution X-ray Scattering of TreS. Crystal packing
interfaces had suggested that TreS assembles as a tetramer in
solution. We wondered whether this apparent tetramer (the
“crystal tetramer”) described how TreS assembles in solution
and probed self-assembly of TreS by small-angle X-ray
scattering (SAXS).
Figure 3. Structural homology and active site geometry of TreS. (A)
Superposition of the TreS monomer with its closest structural
neighbor, sucrose-bound structure of Neisseria polysaccharea amylosu-
crase (PDB entry 1ZS214). Sticks in magenta indicate the
amylosucrase-bound sucrose, and sticks in green indicate the TreS
catalytic residues (Asp238, Glu280, and Asp350), with Ca2+ site as a
sphere in salmon. (B) Position of sucrose (sticks in gray) in the active
site of TreS (chain A), based on the structural superposition in panel
A. The side chains of the catalytic triad of TreS (green) and
amylosucrase (cyan) are shown. The β7−β8 loop (yellow) overlaps
with the putative substrate binding site. (C) Molecular surfaces of
chains A and B in the TreS tetramer. Spheres in light blue represent
sucrose according to the superposition in panel A, while the β7−β8
loop is shown as a ribbon (yellow). (D) Close-up view of the cavity
between the active sites of chains B and A (view of panel C rotated by
180° about the vertical axis). The surface of chain A is left transparent
to reveal the location of the catalytic residues and of the (modeled)
substrate.
ACS Chemical Biology Articles
dx.doi.org/10.1021/cb400508k | ACS Chem. Biol. 2013, 8, 2245−22552247
Guinier plot analysis (PRIMUS20) conﬁrmed that TreS does
not aggregate in the solution state, with a radius of gyration of
Rg = 4.71 nm (Figure S2A, Supporting Information). The
distance distribution function is approximately bell-shaped,
indicative of a globular protein (Figure S2B, Supporting
Information). We next calculated theoretical scattering curves
based on the crystal structure of TreS using CRYSOL,21
assuming monomeric, dimeric, and tetrameric conﬁgurations.
Pronounced deviations from the experimental data are evident
at low scattering angles for calculated curves assuming a
monomer or dimer. In contrast, the tetrameric conﬁguration
was able to reproduce the features of the measured scattering
curve at low scattering angles (Figure 4A), although systematic
deviations are still apparent at s ≥ 0.1 nm−1. The discrepancy
indicates that the arrangement of the subunits in the solution
tetramer may diﬀer from that in the crystal tetramer, likely
reﬂecting the absence of packing constraints imposed in the
lattice. Nevertheless, a bead model calculated solely on the basis
of the scattering curve (DAMMIF22 and DAMAVER23)
envelops the crystal tetramer and shows internal features
compatible with the tetrameric structure (Figure 4B).
Thus, the solution scattering data indicate that the TreS
tetramer observed in the crystal lattice describes the assembly
in the solution state, although the SAXS-derived molecular
envelope, derived without assuming internal symmetry,
suggests that the solution tetramer is not strictly symmetrical.
TreS and Pep2 Form a Noncovalent Complex. In the
genome of M. tuberculosis, TreS and Pep2 are encoded by
separate genes (Rv0126 and Rv0127, respectively), but they
appear as a gene fusion in a considerable number of bacterial
species.6 We, therefore, investigated whether TreS and Pep2
form a noncovalent complex. First, we examined elution of
TreS and Pep2 from a size exclusion resin. Calibration of the
resin using bovine serum albumin (BSA) showed a dominant
monomer peak at 137 mL (66.5 kDa) and a weaker dimer peak
at 116 mL (133 kDa), consistent with published data.24
Trehalose synthase (monomer mass 72 kDa) on its own eluted
with a dominant peak at 107 mL (Figure S3A, Supporting
Information), while M. tuberculosis Pep2 (monomer mass 52
kDa) showed a continuous size distribution with three distinct
peaks at 108, 114, and 149 mL. Compared to the BSA standard,
these peaks could represent tetrameric, trimeric, and mono-
meric assembly states of Pep2, respectively. Analyzing the
elution of a mixture of TreS with Pep2 (nominal molar ratio of
1:2) resulted in a dominant peak at 98 mL, over a background
of a size distribution that resembled that of Pep2 alone.
Analyzing the elution fractions by denaturing polyacrylamide
gel electrophoresis (SDS-PAGE; Figure S3B, Supporting
Information) demonstrates that the peak at 98 mL includes
TreS and Pep2 in approximately equal parts (by visual
inspection of band intensity), whereas on its own, Pep2 starts
eluting from the column only at 105 mL, with the peak
fractions eluting between 110 and 115 mL. Thus, TreS and
Pep2 coelute and do so earlier than on their own, strongly
suggesting complex formation.
Stoichiometry of the TreS:Pep2 Complex. Next, we
analyzed the sedimentation behavior of TreS and Pep2 by
analytical ultracentrifugation. In the absence of Pep2, TreS
sediments at a sedimentation coeﬃcient of 11S, with a much
smaller maximum at 16S (Figure 5A). Fitting a single frictional
coeﬃcient, these two peaks correspond to molecular masses of
260 000 and 470 000, respectively, indicating that TreS exists
predominantly as a tetramer in solution (monomer mass of
TreS is 72 kDa), with only a weak tendency of forming higher
oligomers. The fact that two peaks are seen is indicative that the
exchange between the tetramer and octamer is slow on the time
scale of sedimentation (ca. 10−5 s−1). No evidence of a TreS
monomer or dimer was found in this velocity experiment or the
size exclusion proﬁle. When analyzed on its own, Pep2 displays
maxima at sedimentation coeﬃcients of 3.8S and 8.9S,
corresponding to molecular masses of 54 000 and 188 000,
respectively. Compared to the calculated mass of recombinant
Pep2 (52 kDa), the 3.8S peaks represents a Pep2 monomer,
while the 8.9S peak could represent a mixture of Pep2 trimers
and tetramers, which were both apparent in the size exclusion
proﬁle of Pep2.
Adding Pep2 to TreS in molar ratios of 0.25:1, 0.5:1, 1:1, 2:1,
and 4:1 (with respect to monomers), distinctly altered the c(s)
distribution proﬁle. The peak at 11S, representing the TreS
tetramer, shifted continually to about 13.1S until the molar
ratio was 2:1, and changed only slowly thereafter (Figure 5A +
inset). Within in the limits of the resolution of the c(s)
distribution, the proﬁles indicated a continuous shift of the
original 11S peak, rather than this peak disappearing and a new
peak (at 13.1S) appearing instead. Thus, the c(s) distributions
suggest that Pep2 gradually associates with the tetramer of TreS
in a fast exchange on the time scale of sedimentation. The
shifted TreS peak (13.1S) at a 4:1 ratio of Pep2:TreS
corresponds to 345 kDa, ﬁtted with a single frictional ratio.
This mass would be compatible with four TreS plus two Pep2
subunits. However, ﬁtting only a single frictional ratio, which
varied between 1.11 and 1.48 (Figure S4A, Supporting
Information), for a complex mixture of species, signiﬁcant
over- or underestimates of actual masses are possible.
Therefore, we performed an analysis of the TreS:Pep2 complex
by analytical ultracentrifugation in sedimentation equilibrium
Figure 4. Solution small-angle X-ray scattering analysis of TreS. (A)
Scattering curves for TreS calculated on the basis of the TreS structure
in monomeric, dimeric, and tetrameric conﬁguration are superimposed
over the measured scattering curve. (B) Envelope of the TreS tetramer
determined by ab initio calculation from the solution scattering data
and superimposed over the crystal tetramer of TreS.
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mode. A mixture of Pep2:TreS at nominal molar ratio of 2:1
was analyzed at 3 diﬀerent concentrations and 3 diﬀerent
rotation speeds (Figures 5B, S4B, and S4C, Supporting
Information).
Assuming that only a single species (the TreS:Pep2 complex)
is present and ﬁtting its molecular weight yielded an
experimental mass of 452 861 Da [±4670 Da] (global ﬁt
over data from three speeds and three sample concentrations),
but still led to systematic deviations in the residual plots. In
contrast, a model of 2 noninteracting species in which Pep2
(present at a 2:1 molar ratio to TreS) was assumed to remain
monomeric when not part of the TreS:Pep2 complex, led to a
ﬁtted mass of 506 101 Da [±9975 Da] (global ﬁt) for the
complex, with residuals showing no systematic deviation
(Figure s5B, S4B, and S4C, Supporting Information). Thus,
the ﬁtted mass of the TreS:Pep2 complex is most compatible
with a complex of TreS tetramer bound to four Pep2 subunits
(calculated mass 491 000).
Pep2 Activity Varies in the Presence of TreS in a
Dose-Dependent Fashion. Initially, we probed activities of
recombinant trehalose synthase and maltokinase in an end-
point assay, monitoring reaction products by thin layer
chromatography.7 Incubation of TreS with trehalose or maltose
interconverted the substrates (Figure S5A, Supporting
Information), as reported previously for M. smegmatis TreS.25
At high enzyme concentrations, we also observed the hydrolysis
of the disaccharide to glucose, as reported for M. smegmatis
TreS.17,25 Incubating trehalose with both TreS and Pep2
produces maltose-1-phosphate (Figure 6A, lanes 11−13).
Phosphorylation of maltose is ATP-dependent (Figure 6A,
lane 8), consistent with previous evidence,26 but Pep2 does not
phosphorylate trehalose under the assay conditions (Figure 6A,
lane 6). Likewise, TreS does not produce a phosphorylated
sugar when incubated with either trehalose or maltose (Figure
6A, lanes 4 and 5). Thus, the 2-step conversion from trehalose
to maltose-1-phosphate occurs only when both enzymes, TreS
and Pep2, are present.
We then asked whether complex formation between TreS
and Pep2 aﬀects the catalytic activity of the constituent
enzymes. To this end, we designed a continuous enzyme assay
that quantiﬁed Pep2-catalyzed phosphorylation of maltose by
coupling ATP-to-ADP conversion to oxidation of NADH,
monitoring the latter ﬂuorimetrically. Varying maltose at a ﬁxed
initial ATP concentration or varying ATP at a ﬁxed initial
maltose concentration resulted in Michaelis−Menten type
kinetics in both cases (Figures 6B,C). Fixing ATP at 0.5 mM
and increasing the concentration of TreS (from nil to a molar
ratio of 4 TreS to 1 Pep2) tripled Vmax in a nearly linear fashion
(Figures 6C and S5B, Supporting Information; Table 2). In
contrast, KM increased moderately from the TreS-free to the
TreS:Pep2 complex state, after which any change remained
within the experimental error (Figure S5C, Supporting
Information; Table 2). Varying ATP at a ﬁxed maltose
concentration (20 mM) mirrored this pattern in that Vmax
even quadrupled, while the KM for ATP increased when TreS
was added, but remained invariant within error for [TreS]/
[Pep2] ratios ≥ 1 (Figures 6C, S5B, and S5C, Supporting
Information; Table 2). This eﬀect was protein-speciﬁc: adding
bovine serum albumin (BSA) to Pep2 at the same molar ratios
resulted in changes of activity that were nonsystematic and
distinctly smaller in magnitude (±30%; Figure S5D, Supporting
Information), underscoring that the pronounced and dose-
dependent increase of Vmax of Pep2 was speciﬁc for TreS, likely
a consequence of complex formation.
In order to test whether complex formation also aﬀected the
activity of TreS, we monitored M. smegmatis TreS-catalyzed
conversion of trehalose to glucose in an enzyme-coupled
continuous assay (see Methods). Since the coupling reactions
involved conversion of ATP to ADP, it was necessary to rule
out ATP depletion by Pep2-catalyzed conversion of maltose to
maltose-1-phosphate. We designed three point mutants of M.
smegmatis Pep2 (K145A, Q309A, and D321A) aiming to
abrogate ATP binding. Two of these mutants (K145A and
D321A) showed activity levels that were indistinguishable from
the baseline of the assay (Figure S6A, Supporting Information).
We chose the Pep2-K145A mutant for further experimentation,
verifying by size exclusion chromatography that this mutant still
formed a complex with TreS (Figure S6B, Supporting
Figure 5. Sedimentation behavior of TreS in the absence and presence
of Pep2. (A) Sedimentation velocity analysis of TreS, Pep2, and molar
mixtures of the two as indicated on the right of the panel (absolute
concentration of TreS at 4.5 μM). With the exception of the trace in
blue (Pep2 alone, 9 μM), c(s) traces have been spaced along the
vertical axis according to the molar ratio of [Pep2]/[TreS]. Arrows
indicate the positions of the Pep2 monomer and TreS tetramer,
respectively. The dashed line highlights the shift of the TreS tetramer
peak in response to the addition of Pep2. (Inset) Sedimentation
coeﬃcient of the TreS tetramer peak as a function of the concentration
ratio [Pep2]/[TreS]. (B) Sedimentation equilibrium analysis of the
TreS:Pep2 complex. Fit of a noninteracting species model consisting
of the TreS:Pep2 complex and free Pep2 (ﬁxed at 52 kDa). TreS and
Pep2 are at a concentration of 5 and 10 μM, respectively. Rotation
speeds are indicated. Equilibrium was allowed to establish over a 24 h
period at each speed, and several absorbance scans were recorded per
rotation speed, the last of each was used in the data analysis.
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Information). Because of trace contaminations of glucose in the
substrate, we were limited to probing activity at trehalose
concentrations of less than half the KM (∼85 mM).
17 We,
therefore, compared the slopes Δvi/Δ[Tre] of the vi vs [Tre]
plot at diﬀerent ratios of [Pep2-K145A]/[TreS] and calibrated
the resulting slopes against activity measurements at diﬀerent
TreS concentrations (without Pep2 present), thus mimicking
an increase or decrease in TreS hydrolysis activity (Figure S6C,
Supporting Information). We observed a systematic increase of
TreS-catalyzed hydrolysis as Pep2-K145A was added up to a
molar ratio [Pep2-K145A]/[TreS] of 4. However, the change
was small, exceeding only slightly the unsystematic variation
observed when adding BSA (Figure S6D, Supporting
Information) and remaining distincly below the increase of
activity observed when doubling the TreS concentration
(Figures 6D and S6C, Supporting Information). We conclude
that complex formation increases Pep2 activity markedly, but
aﬀects TreS activity to a far lesser extent.
Figure 6. Activity of TreS and Pep2 and evidence for TreS aﬀecting Pep2 activity. (A) Thin layer chromatography analysis of reaction products
demonstrating Pep2-catalyzed conversion of maltose to maltose-1-phosphate and conversion of trehalose to maltose-1-phosphate when both TreS
and Pep2 are present. (B,C) Michaelis−Menten kinetics of M. tuberculosis Pep2 activity, monitored by an enzyme-coupled assay (see Methods).
Experiments were done in triplicate and Michaelis−Menten parameters (Table 2) determined using the GraphPad Prism software. (D) Hydrolysis
activity of M. smegmatis TreS (0.4 μM) in the absence and presence of M. smegmatis Pep2-K145A. Molar ratios of Pep2-K145A:TreS are indicated,
and data points for [TreS] = 0.8 μM (Figure S6C, Supporting Information) are included for comparison. Data points were ﬁtted to a linear function
(vi = k[Tre]).
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Evidence for TreS:Pep2 Complex Formation in Vivo. In
order to probe whether TreS and Pep2 form a complex in vivo,
we overexpressed and puriﬁed His6-tagged M. smegmatis Pep2
from cell extracts of Mycobacterium smegmatis mc2155 using Ni-
NTA and ion exchange chromatography. To detect endoge-
nous TreS, we analyzed column fractions for their ability to
convert trehalose to maltose-1-phosphate, which requires the
presence of both TreS and Pep2. As the puriﬁcation involved
two successive chromatography steps, in which the Ni-NTA
matrix selected for the His-tagged Pep2, observation of TreS
activity indicated complex formation. Coomassie-staining failed
to visualize endogenous TreS enzyme on the SDS gel of the
untreated column fractions (Figure 7A, main panel), but thin-
layer chromatography showed fraction-speciﬁc conversion of
trehalose to maltose-1-phosphate (Figure 7B). Concentrating
Table 1. X-ray Diﬀraction Data and Reﬁnement Statistics
X-ray diﬀraction data
beamline Diamond I04
wavelength (Å) 0.9795
space group P3212
cell parameters a,b,c (Å) 161.6, 161.6, 139.1
molecules per asymmetric unit 2
resolution (Å) 29.2−2.60
high resolution shell (Å) 2.74−2.60
Rmerge
a (%) 6.0 (66.8)
total observations 298633
unique reﬂections 63561
I/σ(I)a 16.1 (1.7)
completenessa (%) 99.6 (99.6)
multiplicitya 4.7 (4.7)
reﬁnement
resolution range (Å) 29.16−2.60
unique reﬂections 60392
Rcryst (%) 21.3
Rfree (%) 24.0
No. of non-hydrogen atoms 8845
protein 8737
solvent 108
rmsd bonds (Å) 0.006
rmds angles (deg) 1.0
B-factors
wilson (Å2) 70.6
average (Å2) 69.2
protein (Å2) 69.1
solvent (Å2) 74.1
rmsd B-factors 1.3
ramachandran plotb
favored (%) 96.9
allowed (%) 3.1
disallowed (number) 0
score, percentilec 1.65, 99th
aNumbers in parentheses refer to the high resolution shell.
bRamachandran analysis of backbone dihedral angles was done using
Molprobity (molprobity.biochem.duke.edu). cThe Molprobity score
provides, on a scale of X-ray resolution, an overall assessment of the
quality of the protein geometry relative to a set of reference structures;
the 100th percentile is among the best, the 0th percentile among the
worst structures at comparable resolution (N = 6237; 2.6 Å ± 0.25 Å).
Table 2. Michaelis−Menten Parameters of Pep2-Catalyzed Phosphorylation of Maltose
[TreS]/[Pep2] 0 1:1 2:1 4:1
Maltose ([ATP] = 0.5 mM)
Vmax (μmol min
−1 mg−1) 707 ± 50 1164 ± 148 1625 ± 399 2170 ± 360
KM (mM) 0.17 ± 0.04 0.341 ± 0.12 0.540 ± 0.31 0.457 ± 0.19
kcat (sec
−1) 613.6 1010.4 1410.6 1883.7
kcat/KM (sec
−1 M−1 106) 3.71 2.96 2.61 4.12
ATP ([Mal] = 20 mM)
Vmax (μmol min
−1 mg−1) 1185 ± 70 1904 ± 76 3416 ± 146 4164 ± 221
KM (mM) 0.031 ± 0.005 0.050 ± 0.005 0.058 ± 0.006 0.049 ± 0.007
kcat (sec
−1) 1028.6 1652.8 2965.3 3614.6
kcat/KM (sec
−1 M−1 106) 33.7 33.1 51.5 73.2
Figure 7. Evidence for formation of the TreS:Pep2 complex in M.
smegmatis mc2155. (A) His6-tagged Pep2 was puriﬁed from M.
smegmatis extracts by Ni-NTA and ion exchange chromatography, and
anion exchange column fractions were analyzed by Coomassie-stained
SDS-PAGE, with NaCl concentrations (in M, across the top), and
molecular weight standards (in kDa, on the left) as indicated. FT =
ﬂow through. (A, inset) Coomassie-stained SDS-PAGE of ion
exchange fractions eluted at 0.35 and 0.4 M NaCl after ∼20-fold
concentration, ﬂanked by TreS- and Pep2 controls. (B) Thin-layer
chromatogram of reactions mixtures (100 μL) containing 100 mM
trehalose (Tre) and 20 μL of fractions of the anion exchange column
fractions shown in panel A. The position of maltose-1-phosphate
(M1P) and NaCl concentrations (in M) are indicated. Arrows
highlight the two fractions producing maltose-1-phosphate.
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the maltose-1-phosphate producing fractions 20-fold revealed
two bands that line up with TreS and Pep2 controls,
respectively (Figure 7A, inset). Taken together these results
provide evidence that TreS and Pep2 form a complex in the
cellular context.
■ CONCLUSIONS AND FINAL REMARKS
To our knowledge, complex formation between TreS and Pep2
in mycobacteria has not been reported previously but is perhaps
not surprising given the treS-pep2 gene fusion in a considerable
number of bacterial species.6 Yet the size of this complex (a
hetero-octamer of ∼0.5 × 106 Da) is unexpected. A survey of
structural neighbors of TreS (according to analyses of crystal
packing interfaces) suggests that monomeric and dimeric
biological assemblies prevail by far. Our data indicate that the
TreS-Pep2 hetero-octamer is built on the platform of a TreS
tetramer. On the basis of size exclusion chromatography, a
hexameric assembly has previously been reported for M.
smegmatis TreS.25 However, size exclusion, in a strict sense,
sizes on hydrodynamic radii rather than mass; hence, accurate
mass estimates are diﬃcult to obtain. In contrast, our analytical
ultracentrifugation and SAXS data clearly indicate a tetramer as
the preferred assembly state of TreS in solution. The shift of
the dominant TreS tetramer peak to higher S-values in the c(s)
proﬁle on adding Pep2 indicates that Pep2 subunits bind to the
TreS tetramer, as opposed to the TreS tetramer dissociating
and reassembling into a TreS:Pep2 octameric complex. The
complex appears to be in equilibrium between the octameric
state and a state of free Pep2 and free TreS tetramer, as
including free Pep2 in the model removed systematic deviations
between data and ﬁt. Excess of one or the other partner appears
to be required to reach a saturated complex, which is also
consistent with the inﬂuence of TreS on Pep2 activity.
Complex formation with TreS signiﬁcantly upregulates the
activity of Pep2, an eﬀect that is not explained by nonspeciﬁc
protein−protein interactions, as the BSA control demonstrates.
While activity of TreS also increases in response to complex
formation, the eﬀect is subtle by comparison. In the absence of
a structure for Pep2 (or the Pep2:TreS complex), the
mechanistic basis of the 3-fold (maltose) or 4-fold (ATP)
increase of Vmax is not obvious, but complex formation might
drive Pep2 into a conformation that favors catalysis by reducing
the sampling of conformational states that are compatible with
substrate binding but do not allow turnover.
A key requirement during α-glucan synthesis is to avoid
accumulation of toxic pathway intermediates. Stress by
increased levels of maltose-1-phosphate appears to result in
inhibition of respiration and the induction of the SOS regulon,
which controls the DNA damage response.7 Complex
formation would be an eﬀective strategy to direct the ﬂow of
pathway intermediates through consecutive catalytic steps. The
open active site of the TreS tetramer and the tunnel between
the active sites within the TreS tetramer would oﬀer several
mechanistic options for docking of partner enzymes and the
eﬃcient transfer of pathway intermediates. Thus, our study
provides a ﬁrst hint to the intriguing possibility of the GlgE
pathway being organized as a multicatalytic machinery that
controls the ﬂow of pathway intermediates by complexation
between pathway enzymes.
■ METHODS
Recombinant Proteins. The genes of M. tuberculosis trehalose
synthase treS (Rv0126) and pep2 (Rv0127) were ampliﬁed by
polymerase chain reaction (PCR, primers in Table S1, Supporting
Information) from M. tuberculosis H37Rv genomic DNA. The PCR
products were ligated into NdeI and HindIII sites of plasmid pET28a
(Novagen). E. coli BL21 (DE3) cells were heat-transformed with
plasmids, encoding either TreS or Pep2, and cultured on agar plates
(LB/kanamycin 25 μg/mL). A single colony was used to inoculate 10
mL of LB broth, 1% (w/v) glucose, and kanamycin (25 μg/mL),
followed by incubation overnight (37 °C). The liquid culture was
centrifuged and resuspended in fresh Terriﬁc Broth media (TB27) with
kanamycin (50 μg/mL), and incubated at 37 °C (200 rpm). At OD600
= 0.4, the cultures cooled to 16 °C for 3 h, and protein expression was
induced using 1 mM IPTG (TreS) or 0.1 mM IPTG (Pep2), followed
by further incubation (21 h, 16 °C, 200 rpm). Cells were harvested
(7000g, 10 min), washed with phosphate buﬀered saline (PBS),
resuspended in 30 mL lysis buﬀer (25 mM HEPES-NaOH pH 7.6, 1
M NaCl, 20% (v/v) glycerol), and frozen at −80 °C until further use.
Protease inhibitor cocktail (Roche), 1 mM PMSF, 10 mM MgCl2,
and 10 μg/mL DNase I were added to the resuspended cell pellet,
which was passed 4 times through a French Press (Thermo Spectronic
FA-078). The cleared lysate (27,000g, 30 min, 4 °C), was diluted 4-
fold with buﬀer A (25 mM HEPES-NaOH pH 7.6, 1 M NaCl, 10% (v/
v) glycerol), ﬁltered (0.45 μm pore size), and loaded on a pre-
equilibrated Ni-NTA column (5 mL, GE Healthcare). The column
was washed with buﬀer A (5 column volumes), and buﬀer A + 20 mM,
40 mM, and 60 mM imidazole, respectively. The protein was eluted
with 500 mM imidazole in buﬀer A, and fractions were analyzed by
SDS-PAGE. The eluate was diluted 20-fold with buﬀer B (20 mM Bis-
Tris pH 6.5), ﬁltered (0.45 μm), and applied on a HiTrap Q-column
(1 mL, GE Healthcare Life Sciences) pre-equilibrated with 20 mM Bis-
Tris pH 6.5 and 50 mM NaCl. The column was washed with buﬀer B
supplemented with NaCl (50 to 500 mM, steps of 50 mM). Fractions
were analyzed by SDS-PAGE and pooled, followed by concentration in
Amicon Ultra-4 centrifugal ﬁlter units, then loaded on a HiPrep
Sephacryl 26/60 S-200HR column (GE Healthcare). Fractions
containing protein were concentrated as described before.
Crystallization and Structure Determination. Crystals of TreS
were grown by vapor diﬀusion in 96-well plates, using a Mosquito
liquid handling system (TTP Labtech) to set up crystallization drops
containing 100 nL of TreS (80 mg mL‑1) + 100 nL of reservoir
solution. Sizable crystals grew over a reservoir of 0.1 M sodium citrate
pH 5.6, 0.5 M (NH4)2SO4, and 1 M Li2SO4. Crystals were soaked in
mother liquor supplemented with either 15% (v/v) glycerol or 100
mM maltose or both, and frozen in liquid nitrogen. Diﬀraction data
were recorded from a single crystal on beamline I04 (Diamond Light
Source, Table 1). Data were processed and scaled (XDS and
XSCALE28) and the structure phased by molecular replacement
(PHASER29) using an ensemble of aligned search models (PDB
entries 2ZE0,30 1UOK,31 2PWE,18 1WZA32), truncating nonconserved
side chains (CHAINSAW33). Using 2-fold noncrystallographic
symmetry averaging of the MR-phased map led to interpretable
density, and the model was completed through iterative rounds of
building and reﬁnement (COOT34 and REFMAC535).
Small Angle X-ray Scattering. Solution scattering data of TreS
(concentration range 8.1 to 2.3 mg mL−1) were recorded on beamline
BM29 at ESRF, Grenoble. The protein was buﬀered in 20 mM Bis-
Tris pH 6.5, 150 mM NaCl, and the sample cell equilibrated at 20 °C.
Exposures comprised 10 frames exposed for 2 s each in ﬂow mode,
which were merged. The detector images were integrated and reduced
to 1-dimensional scattering curves, and buﬀer contributions to
scattering were subtracted using the beamline software BsxCuBE.
Scattering curves were displayed using the program PRIMUS.20 All
SAXS data analyses were performed using programs of the ATSAS
suite version 2.5 (www.embl-hamburg.de/biosaxs/software.html).
Size Exclusion Chromatography. The elution of TreS and Pep2,
a 2:1 molar mixture of Pep2:TreS from a Sephacryl S-200HR resin
(320 mL column volume), was monitored by UV absorbance at 280
nm with a ﬂow rate of 0.5 mL/min, and fractions (5 mL) were
analyzed by SDS-PAGE. Proteins were in 20 mM Bis-Tris pH 6.5, 150
mM NaCl.
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Analytical Ultracentrifugation. Sedimentation velocity and
equilibrium experiments used a Beckman Optima XL-A analytical
ultracentrifuge equipped with absorbance optics. Protein samples were
dialyzed into 20 mM Bis-Tris pH 6.5, 150 mM NaCl, and, for the
velocity experiments, loaded into cells with 2-channel Epon center-
pieces and quartz windows. A total of 120 absorbance scans (280 nm)
were recorded (25 000 rpm, 20 °C) for each sample, representing the
full extent of sedimentation of the sample. Data analysis was
performed using SEDFIT, ﬁtting a single frictional ratio (Figure
S4A, Supporting Information).36 The sedimentation equilibrium
experiment (96 h total duration) was conducted at a rotor temperature
of 4 °C. Samples buﬀered as above were loaded into 6-channel Epon
centerpieces with quartz windows, and data were recorded at 6000,
7000, and 8000 rpm, respectively, at three diﬀerent sample
concentrations (see captions of Figures 5 and S4, Supporting
Information). At each rotation speed, the sample was allowed to
reach equilibrium during a 24 h period. The data analysis was
performed using SEDPHAT.37 Parameters for solvent density and
viscosity and for the partial speciﬁc volume (vp̅) of the proteins were
calculated using SEDNTERP (sednterp.unh.edu).
Overexpression of Pep2 in M. smegmatis. DNA primers
(Table S1, Supporting Information) were obtained from MWG, and
DNA of the M. smegmatis pep2 gene was ampliﬁed by PCR. The
puriﬁed PCR fragment (Qiagen) was ligated into the pSD26 plasmid
(BamH1 and EcoRV), which was transformed into M. smegmatis
mc2155 cells by electroporation. Cells were selected on LB/hygB+ (50
μg/mL) agar plates, and a single colony was used to inoculate a 3 mL
culture (LB/hygB+ at 50 μg/mL + 0.05% Tween-80) and grown for 2
d at 37 °C. The culture was propagated (1% v/v inoculation) into 50
mL (2 d growth) and 1 L, grown to midlog phase, induced with 0.2%
w/v acetamide, and incubated overnight (16 °C). Cells were harvested
(7000g, 10 min, 4 °C), resuspended in 25 mM Hepes-NaOH, pH 7.5,
300 mM NaCl, 10% v/v glycerol, 1 mM β-mercaptoethanol, 10 mM
MgSO4, DNase, and lysozyme, and lysed by sonication (12 cycles of
60 s on, 90 s oﬀ at maximum amplitude). The lysate was cleared (27
000g, 30 min, 4 °C), the supernatant ﬁltered (0.45 μm) and loaded on
a pre-equilibrated Ni-NTA HiTrap HP column (GE Life Science, 5
mL) and washed with buﬀer A (25 mM Hepes-NaOH, pH 7.5, 300
mM NaCl, 10% v/v/glycerol) adding imidazole in steps of 20, 40, 60,
80, 100, 150, 200, 250, 300, and 500 mM (5 column volumes per
step). Protein containing fractions were analyzed by SDS-PAGE,
pooled, and diluted 6-fold into buﬀer B (20 mM Bis-Tris pH 6.0, 10%
glycerol) prior to loading on an anion exchange column (HiTrap
QHP, 1 mL, GE Life Science). Protein was eluted with a stepwise
NaCl gradient (Figure 7A).
Generation of Inactive Pep2 Mutants. A structural model for
Pep2 was generated using the fold prediction server Phyre2 (http://
www.sbg.bio.ic.ac.uk/phyre2)38 based on the sequence ofM. smegmatis
Pep2. Comparison with ATP-bound structural homologues suggested
three residues (K145, Q309, and D321) as critical for Mg2+ and/or
ATP binding. Individual point mutations to alanine were introduced
into the pep2 gene of M. smegmatis using the Quikchange approach
(Stratagene, primers in Table S1, Supporting Information). The His6-
tagged proteins were expressed and puriﬁed as described for wild-type
Pep2. Activity of the mutants was tested with the assay described
below (Figure S6A, Supporting Information).
End Point Assays Probing Trehalose Synthase and
Maltokinase Activity. Reaction mixtures probing TreS activity
were in a ﬁnal volume of 100 μL, containing 50 mM HEPES-KOH
buﬀer (pH 7.5), 100 mM maltose or trehalose, and TreS. Reaction
mixtures probing maltokinase activity (100 μL) consisted of 50 mM
HEPES-KOH buﬀer, pH 7.5, 10 mM MgCl2, 5 mM ATP, and 560 nM
Pep2 and were initiated by the addition of 100 mM maltose. All
reactions were at 37 °C for 1 h and stopped by adding an equal
volume of ice-cold acetone, followed by centrifugation (20 000g, 4 °C,
10 min). The supernatant was transferred and dried by speedvac
(Hetovac). To discriminate trehalose from maltose, the dried reaction
product was dissolved in 200 μL water and 2 μL of the solution
applied on silica gel concentrating zone HPTLC plate (Merck,
Darmstadt, Germany) and developed in the solvent system butanol/
pyridine/water (7:3:1 v/v/v). In order to detect phosphorylated
reaction products (Figures 6A and 7B), maltose-1-phosphate was
separated from maltose using aluminum backed silica gel 60 F254 TLC
plates (Merck, Darmstadt, Germany), using the solvent system
butanol/ethanol/water (5:3:2 v/v/v), developing the plate three
times in the same solvent system. Conversion of trehalose to maltose-
1-phosphate was probed by incubating both TreS (140 nM) and Pep2
(0, 35, 70, and 140 nM) in a reaction mixture (50 mM HEPES-KOH
buﬀer, pH 7.5, 10 mM MgCl2, 5 mM ATP) and initiating turnover
with 100 mM trehalose as substrate. To visualize the products, the
dried TLC plates were sprayed with α-naphthol sulfuric acid stain,
followed by mild charring with a heat gun.
Continuous Assay. In order to monitor phosphorylation of
maltose, conversion of ATP to ADP was enzymatically coupled to
oxidation of NADH (via pyruvate kinase and lactate dehydrogenase),
and the latter monitored ﬂuorimetrically (excitation 340 nm and
emission 450 nm). Fluorescence units were converted to concen-
trations of ADP by an internal calibration curve for NADH. The assays
were performed in triplicate in 96-well plates, using a BMG
PHERAstar FS microtiter plate reader and MARS and GraphPad
Prism software to record and analyze data, respectively.
Reaction mixtures contained 50 mM HEPES-NaOH (pH 7.5), 50
mM NaCl, 10 mM MgCl2, and Pep2 at 0.2 μM (when varying ATP)
or 1.2 μM (when varying maltose), adding TreS to ﬁnal molar ratios
[TreS]/[Pep2] of 0, 1, 2, and 4. The coupling reagents were present at
these initial concentrations: 4 mM phosphoenolpyruvate, 2 units of
pyruvate kinase, 2 units of lactate dehydrogenase, and 0.1 mM NADH.
Enzymatic activity of TreS was quantiﬁed by monitoring conversion
of trehalose to glucose (the hydrolysis side reaction),17 coupling
formation of glucose to oxidation of NADH (monitored as above) via
hexokinase, pyruvate kinase, and lactate dehydrogenase. The reaction
mixtures contained 50 mM HEPES-NaOH (pH 7.5), 50 mM NaCl, 1
mM MgCl2, 1.2 μM ATP, 4 mM phosphoenolpyruvate, and 0.1 mM
NADH in addition to 0.5 units of hexokinase and 2 units each of
pyruvate kinase and lactate dehydrogenase. Reactions were initiated by
TreS (0.4 μM ﬁnal concentration) or the TreS:Pep2 complex (TreS at
0.4 μM) at varying molar ratios of Pep2 to TreS for trehalose
concentrations from 0 to 25 mM. Above 40 mM trehalose, instant
NADH oxidation became noticeable in the absence of TreS,
suggesting that the trehalose batch used contained trace amounts of
glucose. Given a KM of ∼85 mM for trehalose,
17 the glucose
contamination precluded the determination of the Michaelis
parameters of the reaction. Instead, slopes Δvi/Δ[Tre] of the vi vs
[Tre] plot were compared to assess changes in enzymatic activity in
response to the addition of Pep2. To calibrate changes of enzyme
activity, we tested hydrolysis activity at TreS concentrations between
0.02 and 1.2 μM (Figure S6C, Supporting Information) as well as in
the presence of BSA at variable molar ratios [BSA]/[TreS], with TreS
at 0.4 μM (Figure S6D, Supporting Information).
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